Our Story

Founded by Aamir Ehsan, MD in 2009, CorePath is a leader in cancer diagnostics with the ability to offer morphologic evaluation, second opinion, immunohistochemistry, cytogenetics, FISH, multicolor flow cytometry, molecular genetics, next generation sequencing and liquid biopsy at one location. CorePath is comprised of academically trained board-certified pathologists and clinical lab scientists helping providers care for their patients in the United States and worldwide through expertise, innovation, collaboration and integration.

We encompass the speed, accuracy and technology of commercial labs while cultivating an environment of learning and understanding usually only found in university labs or other academic institutions.